1. Home
  2. RIO vs ALVOW Comparison

RIO vs ALVOW Comparison

Compare RIO & ALVOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RIO
  • ALVOW
  • Stock Information
  • Founded
  • RIO 1873
  • ALVOW 2013
  • Country
  • RIO United Kingdom
  • ALVOW Luxembourg
  • Employees
  • RIO N/A
  • ALVOW 999
  • Industry
  • RIO Metal Mining
  • ALVOW Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RIO Basic Materials
  • ALVOW Health Care
  • Exchange
  • RIO Nasdaq
  • ALVOW Nasdaq
  • Market Cap
  • RIO N/A
  • ALVOW N/A
  • IPO Year
  • RIO N/A
  • ALVOW N/A
  • Fundamental
  • Price
  • RIO $63.53
  • ALVOW $2.34
  • Analyst Decision
  • RIO Buy
  • ALVOW
  • Analyst Count
  • RIO 4
  • ALVOW 0
  • Target Price
  • RIO $73.00
  • ALVOW N/A
  • AVG Volume (30 Days)
  • RIO 2.9M
  • ALVOW 15.0K
  • Earning Date
  • RIO 02-19-2025
  • ALVOW 02-27-2025
  • Dividend Yield
  • RIO 6.83%
  • ALVOW N/A
  • EPS Growth
  • RIO 14.71
  • ALVOW N/A
  • EPS
  • RIO 7.07
  • ALVOW N/A
  • Revenue
  • RIO $53,658,000,000.00
  • ALVOW $393,919,000.00
  • Revenue This Year
  • RIO $2.38
  • ALVOW N/A
  • Revenue Next Year
  • RIO N/A
  • ALVOW N/A
  • P/E Ratio
  • RIO $9.49
  • ALVOW N/A
  • Revenue Growth
  • RIO N/A
  • ALVOW 517.92
  • 52 Week Low
  • RIO $57.85
  • ALVOW $2.33
  • 52 Week High
  • RIO $74.24
  • ALVOW $2.33
  • Technical
  • Relative Strength Index (RSI)
  • RIO 58.23
  • ALVOW N/A
  • Support Level
  • RIO $61.24
  • ALVOW N/A
  • Resistance Level
  • RIO $64.74
  • ALVOW N/A
  • Average True Range (ATR)
  • RIO 1.03
  • ALVOW 0.00
  • MACD
  • RIO 0.22
  • ALVOW 0.00
  • Stochastic Oscillator
  • RIO 77.59
  • ALVOW 0.00

About ALVOW Alvotech Warrant

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Share on Social Networks: